Global Markets

Viiv Healthcare, owned by GSK (GSK LN), announced its long-acting HIV treatment Cabenuva meets primary endpoint of superior viral suppression in people with viremia

StockNow breaking-news AI analysis

ViiV Healthcare announced Cabenuva met its primary endpoint for superior viral suppression in people with viremia, but retrieved evidence lacks supporting trial details.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more